Enveric Biosciences, Inc. Common Stock (ENVB) is a publicly traded Healthcare sector company. As of May 21, 2026, ENVB trades at $2.21 with a market cap of $4.27M and a P/E ratio of -0.16. ENVB moved +6.16% today. Year to date, ENVB is -45.41%; over the trailing twelve months it is -86.42%. Its 52-week range spans $1.71 to $99.90. Rallies surfaces ENVB's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Enveric Biosciences, Inc. Common Stock (ENVB) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. ENVB moved +6.16% today.
| Metric | Value |
|---|---|
| Price | $2.21 |
| Market Cap | $4.27M |
| P/E Ratio | -0.16 |
| EPS | $-13.36 |
| Dividend Yield | 0.00% |
| 52-Week High | $99.90 |
| 52-Week Low | $1.71 |
| Volume | 124.61K |
| Avg Volume | 0 |
| Revenue (TTM) | $-411 |
| Net Income | $-8.22M |
| Gross Margin | 0.00% |
ENVB analyst coverage data. Average price target: $0.00.